These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 19171932)
1. AMP-activated protein kinase phosphorylates R5/PTG, the glycogen targeting subunit of the R5/PTG-protein phosphatase 1 holoenzyme, and accelerates its down-regulation by the laforin-malin complex. Vernia S; Solaz-Fuster MC; Gimeno-Alcañiz JV; Rubio T; García-Haro L; Foretz M; de Córdoba SR; Sanz P J Biol Chem; 2009 Mar; 284(13):8247-55. PubMed ID: 19171932 [TBL] [Abstract][Full Text] [Related]
2. Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG). Worby CA; Gentry MS; Dixon JE J Biol Chem; 2008 Feb; 283(7):4069-76. PubMed ID: 18070875 [TBL] [Abstract][Full Text] [Related]
3. Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway. Solaz-Fuster MC; Gimeno-Alcañiz JV; Ros S; Fernandez-Sanchez ME; Garcia-Fojeda B; Criado Garcia O; Vilchez D; Dominguez J; Garcia-Rocha M; Sanchez-Piris M; Aguado C; Knecht E; Serratosa J; Guinovart JJ; Sanz P; Rodriguez de Córdoba S Hum Mol Genet; 2008 Mar; 17(5):667-78. PubMed ID: 18029386 [TBL] [Abstract][Full Text] [Related]
4. The laforin-malin complex, involved in Lafora disease, promotes the incorporation of K63-linked ubiquitin chains into AMP-activated protein kinase beta subunits. Moreno D; Towler MC; Hardie DG; Knecht E; Sanz P Mol Biol Cell; 2010 Aug; 21(15):2578-88. PubMed ID: 20534808 [TBL] [Abstract][Full Text] [Related]
5. Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation. Fernández-Sánchez ME; Criado-García O; Heath KE; García-Fojeda B; Medraño-Fernández I; Gomez-Garre P; Sanz P; Serratosa JM; Rodríguez de Córdoba S Hum Mol Genet; 2003 Dec; 12(23):3161-71. PubMed ID: 14532330 [TBL] [Abstract][Full Text] [Related]
6. Glycogenic activity of R6, a protein phosphatase 1 regulatory subunit, is modulated by the laforin-malin complex. Rubio-Villena C; Garcia-Gimeno MA; Sanz P Int J Biochem Cell Biol; 2013 Jul; 45(7):1479-88. PubMed ID: 23624058 [TBL] [Abstract][Full Text] [Related]
8. Increased endoplasmic reticulum stress and decreased proteasomal function in lafora disease models lacking the phosphatase laforin. Vernia S; Rubio T; Heredia M; Rodríguez de Córdoba S; Sanz P PLoS One; 2009 Jun; 4(6):e5907. PubMed ID: 19529779 [TBL] [Abstract][Full Text] [Related]
9. Increased laforin and laforin binding to glycogen underlie Lafora body formation in malin-deficient Lafora disease. Tiberia E; Turnbull J; Wang T; Ruggieri A; Zhao XC; Pencea N; Israelian J; Wang Y; Ackerley CA; Wang P; Liu Y; Minassian BA J Biol Chem; 2012 Jul; 287(30):25650-9. PubMed ID: 22669944 [TBL] [Abstract][Full Text] [Related]
10. The level of the glycogen targetting regulatory subunit R5 of protein phosphatase 1 is decreased in the livers of insulin-dependent diabetic rats and starved rats. Browne GJ; Delibegovic M; Keppens S; Stalmans W; Cohen PT Biochem J; 2001 Dec; 360(Pt 2):449-59. PubMed ID: 11716774 [TBL] [Abstract][Full Text] [Related]
11. Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin. DePaoli-Roach AA; Tagliabracci VS; Segvich DM; Meyer CM; Irimia JM; Roach PJ J Biol Chem; 2010 Aug; 285(33):25372-81. PubMed ID: 20538597 [TBL] [Abstract][Full Text] [Related]
12. Laforin-malin complex degrades polyglucosan bodies in concert with glycogen debranching enzyme and brain isoform glycogen phosphorylase. Liu Y; Zeng L; Ma K; Baba O; Zheng P; Liu Y; Wang Y Mol Neurobiol; 2014 Apr; 49(2):645-57. PubMed ID: 24068615 [TBL] [Abstract][Full Text] [Related]
13. PTG, a protein phosphatase 1-binding protein with a role in glycogen metabolism. Printen JA; Brady MJ; Saltiel AR Science; 1997 Mar; 275(5305):1475-8. PubMed ID: 9045612 [TBL] [Abstract][Full Text] [Related]
14. Regulation of the autophagic PI3KC3 complex by laforin/malin E3-ubiquitin ligase, two proteins involved in Lafora disease. Sanchez-Martin P; Lahuerta M; Viana R; Knecht E; Sanz P Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118613. PubMed ID: 31758957 [TBL] [Abstract][Full Text] [Related]
15. Protein degradation and quality control in cells from laforin and malin knockout mice. Garyali P; Segvich DM; DePaoli-Roach AA; Roach PJ J Biol Chem; 2014 Jul; 289(30):20606-14. PubMed ID: 24914213 [TBL] [Abstract][Full Text] [Related]
16. Laforin, a dual-specificity phosphatase involved in Lafora disease, is phosphorylated at Ser25 by AMP-activated protein kinase. Romá-Mateo C; Solaz-Fuster Mdel C; Gimeno-Alcañiz JV; Dukhande VV; Donderis J; Worby CA; Marina A; Criado O; Koller A; Rodriguez De Cordoba S; Gentry MS; Sanz P Biochem J; 2011 Oct; 439(2):265-75. PubMed ID: 21728993 [TBL] [Abstract][Full Text] [Related]
17. Ubiquitin conjugating enzyme E2-N and sequestosome-1 (p62) are components of the ubiquitination process mediated by the malin-laforin E3-ubiquitin ligase complex. Sánchez-Martín P; Romá-Mateo C; Viana R; Sanz P Int J Biochem Cell Biol; 2015 Dec; 69():204-14. PubMed ID: 26546463 [TBL] [Abstract][Full Text] [Related]
18. Protein targeting to glycogen overexpression results in the specific enhancement of glycogen storage in 3T3-L1 adipocytes. Greenberg CC; Meredith KN; Yan L; Brady MJ J Biol Chem; 2003 Aug; 278(33):30835-42. PubMed ID: 12805359 [TBL] [Abstract][Full Text] [Related]